Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-Cell Neoplasm”

5,543 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,543 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04533581
What this trial is testing

Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Indolent B-cell Non-Hodgkin's Lymphoma
Kyowa Kirin Co., Ltd. 61
Testing effectiveness (Phase 2)Looking for participantsNCT07372365
What this trial is testing

Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naïve MZL.

Who this might be right for
Marginal Zone Lymphoma (MZL)
The First Affiliated Hospital of Soochow University 23
Not applicableNot Yet RecruitingNCT05371392
What this trial is testing

Polymorphism of ITGA4 Gene in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Sohag University 80
Large-scale testing (Phase 3)Active Not RecruitingNCT01886872
What this trial is testing

Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Stage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more
National Cancer Institute (NCI) 547
Testing effectiveness (Phase 2)Active Not RecruitingNCT04842877
What this trial is testing

Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
The Lymphoma Academic Research Organisation 141
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Early research (Phase 1)Looking for participantsNCT06547528
What this trial is testing

A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL

Who this might be right for
Relapsed or Refractory T Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Ono Pharmaceutical Co., Ltd. 108
Not applicableUnknownNCT03971565
What this trial is testing

Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Assistance Publique Hopitaux De Marseille 47
Testing effectiveness (Phase 2)Study completedNCT01532700
What this trial is testing

An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
University Health Network, Toronto 28
Early research (Phase 1)Study completedNCT01373229
What this trial is testing

Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
David Rizzieri, MD 21
Testing effectiveness (Phase 2)Study completedNCT02433795
What this trial is testing

Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)

Who this might be right for
Marginal Zone B-cell Lymphoma
Seoul National University Hospital 27
Testing effectiveness (Phase 2)Study completedNCT01246557
What this trial is testing

Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

Who this might be right for
Chronic Lymphatic Leukemia
Hospital Universitari Vall d'Hebron Research Institute 20
Testing effectiveness (Phase 2)UnknownNCT04796857
What this trial is testing

Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCL

Who this might be right for
Non-GCB/ABC Diffuse Large B-Cell LymphomaHigh-grade B-cell LymphomaFollicular Lymphoma Grade IIIb+3 more
Huiqiang Huang 30
Not applicableUnknownNCT00429065
What this trial is testing

Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

Who this might be right for
Non-Hodgkin Lymphoma
Instituto Nacional de Cancerologia de Mexico 30
Testing effectiveness (Phase 2)Study completedNCT02533401
What this trial is testing

Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 34
Large-scale testing (Phase 3)Study completedNCT00329030
What this trial is testing

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

Who this might be right for
Lymphoma, B-CellLymphoma, Large-Cell, ImmunoblasticLymphoma, Non-Hodgkin
National Heart, Lung, and Blood Institute (NHLBI) 224
Testing effectiveness (Phase 2)Looking for participantsNCT05147467
What this trial is testing

Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Ascentage Pharma Group Inc. 75
Testing effectiveness (Phase 2)Study completedNCT03145064
What this trial is testing

Study of BTK Inhibitor Zanubrutinib in Participants With Relapsed/Refractory Non-GCB Type Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
BeiGene 41
Testing effectiveness (Phase 2)UnknownNCT03188198
What this trial is testing

Risk Adapted Therapy in Diffuse Large B Cell Lymphoma

Who this might be right for
Large B Cell Lymphoma
Mansoura University 60
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Load More Results